Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cyclin-dependent kinases in cancer: Role, regulation, and therapeutic targeting
Ashna Gupta, Gunjan Dagar, Ravi Chauhan, et al.
Advances in protein chemistry and structural biology (2023), pp. 21-55
Closed Access | Times Cited: 16

Showing 16 citing articles:

Unveiling the potential effects of resveratrol in lung cancer treatment: Mechanisms and nanoparticle-based drug delivery strategies
Behnam Najafiyan, Zahra Bokaii Hosseini, Samar Esmaelian, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 172, pp. 116207-116207
Open Access | Times Cited: 24
Ubiquitination and deubiquitination: Implications on cancer therapy
Gunjan Dagar, Rakesh Kumar, Kamlesh Yadav, et al.
Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms (2023) Vol. 1866, Iss. 4, pp. 194979-194979
Closed Access | Times Cited: 37
The study of curve fitting models to analyze some degree-based topological indices of certain anti-cancer treatment
Xiujun Zhang, Zainab Saeed Bajwa, Shahid Zaman, et al.
Chemical Papers (2023) Vol. 78, Iss. 2, pp. 1055-1068
Closed Access | Times Cited: 20
Enhancing Cervical Cancer Screening: Review of p16/Ki-67 Dual Staining as a Promising Triage Strategy
Yung‐Taek Ouh, Ho Kim, Kyong Wook Yi, et al.
Diagnostics (2024) Vol. 14, Iss. 4, pp. 451-451
Open Access | Times Cited: 6
Advances in Cancer Therapy: A Comprehensive Review of CDK and EGFR Inhibitors
Mohammed Hawash
Cells (2024) Vol. 13, Iss. 19, pp. 1656-1656
Open Access | Times Cited: 5
Organotin(IV) complexes: Emerging Frontiers in anticancer therapeutics and bioimaging applications
Yang Zi, Fahad A. Alhumaydhi, Waleed Al Abdulmonem, et al.
Coordination Chemistry Reviews (2025) Vol. 534, pp. 216582-216582
Closed Access
Computational and Experimental Insights into Azo-Containing Aroylhydrazones: A Promising Class of CDK2 Inhibitors
Tolga A. Yeşil, Ömer DİLEK, Tahir Tilki
Journal of the Indian Chemical Society (2025), pp. 101764-101764
Closed Access
Cancer therapy by cyclin-dependent kinase inhibitors (CDKIs): bench to bedside.
Ali Hassanzadeh, Navid Shomali, Amin Kamrani, et al.
PubMed (2024) Vol. 23, pp. 862-882
Closed Access | Times Cited: 3
Polyploidy-mediated resilience in hepatic aging: molecular mechanisms and functional implication
Majeed M. A. Ali
Egyptian Liver Journal (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Enhancing Cervical Cancer Screening: Review of p16/Ki-67 Dual Staining as a Promising Triage Strategy
Yung‐Taek Ouh, Ho Yeon Kim, Kyong Wook Yi, et al.
(2024)
Open Access | Times Cited: 2
Insights into Nimbolide molecular crosstalk and its anticancer properties
Shabnum Shaheen, Sana Khalid, Khadija Aaliya, et al.
Medical Oncology (2024) Vol. 41, Iss. 6
Closed Access | Times Cited: 2
Immunotherapeutic effects of de novo benzimidazole derivative and prebiotic bacterial levan against triple-negative breast tumors by harnessing the immune landscape to intercept the oncogenic transcriptome
Heba Shawky, Dalia B. Fayed, Somaia S. Abd El‐Karim, et al.
International Journal of Biological Macromolecules (2024) Vol. 289, pp. 138844-138844
Closed Access | Times Cited: 2
Thymoquinone, a Novel Multi-Strike Inhibitor of Pro-Tumorigenic Breast Cancer (BC) Markers: CALR, NLRP3 Pathway and sPD-L1 in PBMCs of HR+ and TNBC Patients
Sawsan Elgohary, Reda A. Eissa, H.M. El Tayebi
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 14254-14254
Open Access | Times Cited: 4
THF induces apoptosis by downregulating initiation, promotion, and progression phase biomarkers in skin and lung carcinoma
Waseem Raza, Abha Meena, Suaib Luqman
Journal of Biochemical and Molecular Toxicology (2024) Vol. 38, Iss. 9
Closed Access
Bystanders or active players: the role of extra centrosomes as signaling hubs
Madison M. Purkerson, Sarah R. Amend, Kenneth J. Pienta
Cancer and Metastasis Reviews (2024) Vol. 44, Iss. 1
Open Access
Quinazolinone derivatives as new potential CDK4/6 inhibitors, apoptosis inducers and radiosensitizers for breast cancer
Mostafa G.M. El-Gazzar, Marwa G. El‐Gazzar, Mostafa M. Ghorab
Future Medicinal Chemistry (2023) Vol. 15, Iss. 13, pp. 1133-1147
Open Access
Page 1

Scroll to top